Outcome after pediatric heart transplantation: two decades of a single center experience

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 2, 2007, Pages 220-224

  Gambino, Antonio ^a   Cerutti, Alessia ^a   Feltrin, Giuseppe ^a   Toscano, Giuseppe ^a   Tarantini, Giuseppe ^a   Milanesi, Ornella ^a   Angelini, Annalisa ^a   Gerosa, Gino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

CAV; Heart transplantation; Immunosuppressive therapy; Neoplasms; Pediatric; PTLD

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; CARDIOMYOPATHY; CENTRAL NERVOUS SYSTEM TUMOR; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; GRAFT REJECTION; HEART FUNCTION; HEART TRANSPLANTATION; HEART TUMOR; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHODGKIN LYMPHOMA; PEDIATRIC CARDIOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULAR DISEASE; VULVA DISEASE;

ADOLESCENT; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; CREATININE; FEMALE; HEART DEFECTS, CONGENITAL; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; MALE; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 34347397127     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.03.049     Document Type: Article

References (19)

1. Fricker F.J., Griffith B.P., Hardesty R.L., Trento A., Gold L.M., Schmeltz K., Beerman L.B., Fischer D.R., Mathews R.A., and Neches W.H. Experience with heart transplantation in children. Pediatrics 79 (1987) 138-146
2. Webber S.A. The current state of, and future prospects for, cardiac transplantation in children. Cardiol Young 13 (2003) 64-83
3. Smith R.R., Wray J., Khaghani A., and Yacoub M. Ten year survival after paediatric heart transplantation: a single centre experience. Eur J Cardiothorac Surg 27 5 (2005) 790-794
4. Boucek M.M., Mathis C.M., Kanakriyeh M.S., McCormack J., Razzouk A., and Gundry S.R. Bailey donor shortage: use of the dysfunctional donor heart L. J Heart Lung Transplant 12 6 Pt 2 (1993) S186-S190
5. Balzer D.T., Moorhead S., Saffitz J.E., Huddleston C.B., Spray T.L., and Canter C.E. Utility of surveillance biopsies in infant heart transplant recipients. J Heart Lung Transplant 14 (1994) 1095-1101
6. Bouchek M.M., Waltz D.A., Leah B., Edwards B.E., David O., Taylor D.O., Berkley M.K., Trulock E.P., Marshall I., and Hertz M.I. Registry for the International Society for Heart and Lung Transplantation: Ninth Official Pediatric Report-2006. J Heart Lung Transplant 25 (2006) 893-903
7. Baley L.L., Gundry S.R., Razzouk A.J., Wang N., Sciolaro C.M., Chiavarelli M., and the Loma Linda University Pediatric Heart Transplant Group. Bless the babies: 115 late survivors of heart transplantation during the first year of life. J Thorac Cardiovasc Surg 105 (1993) 805-815
8. Penn I. De-novo malignancies in pediatric organ transplant recipients. Pediatr Transplant 2 (1998) 56
9. Caforio A.L.P., Belloni Fortina A., Piaserico S., Alaibac M.S.A., Tona F., Feltrin G., Pompei E., Testolin L., Gambino A., Dalla Volta S., Thiene G., Casarotto D., and Peserico A. Skin cancer in heart transplant recipients: frequency and risk factor analysis and relevance of immunosuppressive therapy. Circulation 102 Suppl 2 (2000)
10. Zangwill S.D., Hsu D.T., Kichuk M.R., Garvin J.H., Stolar C.J., Haddad Jr. J., Stylianos S., Michler R.E., Chadburn A., Knowles D.M., and Addonizio L.J. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. J Heart Lung Transplant 17 12 (1998) 1161-1166
11. Swinnen L.J., Costanzo Nordin M.R., Fisher S.G., O'Sullivan E.J., Johnson M.R., Heroux A.L., Dizikes G.J., Pifarre R., and Fisher RI. Increased incidence of lymphoproliferative disorders after immunosuppression with the monoclonal antibody OKT-3 in cardiac transplant recipients. N Engl J Med 323 (1990) 1723-1728
12. Eisen H.J., Tuzcu E.M., Dorent R., Kobashigawa J., Mancini D., Valantine-von Kaeppler H.A., Starling R.C., Sorensen K., Hummel M., Lind J.M., Abeywickrama K.H., Bernhardt P., and RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 349 9 (2003) 847-858
13. Valantine H, Zuckermann A. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation. J Heart Lung Transplant. 2005;24(4 Suppl):S185-90; discussion S210-1. Review. Erratum in: J Heart Lung Transplant 2005;24(6):787.
14. Phal E., Hornung T., Parry G., and Dark J.H. Pediatric cardiac transplant. Results using a steroid-free maintenance regimen. Pediatr Transplant 7 (2003) 59-63
15. Phal E., Zales V.R., Fricker F.J., and Addonizio L.J. Post transplant coronary artery disease in children. A multicenter national survey. Circulation 90 (1994) 11-56-11-60
16. Cochrane A.D., Adams D.H., Radley Smith R., Khaghani A., and Yacoub M.H. Heterotopic heart transplantation for elevated pulmonary vascular resistance in pediatric patients. J Heart Lung Transplant 14 2 (1995) 296-301
17. Reichert B. Size matching in heart transplantation. J Heart Lung Transplant 11 (1992) S199-S202
18. Tramisier D., Vouhe P., Le Bidois J., Mauriat P., Khoury W., and Leca F. Donor recipient size matching in pediatric heart transplantation: a word of caution about small grafts. J Heart Lung Transplant 15 2 (1996) 190-195
19. Pietra B.A., and Boucek M.M. Immunosuppression for pediatric cardiac transplantation in the modern era. Progress Pediatr Cardiol. 11 (2000) 115-129